Canine leishmaniasis

Advances in Parasitology

Volumn 57, Issue , 2004, Pages 1-88

  Alvar, Jorge ^a   Cañavate, Carmen ^a   Molina, Ricardo ^a   Moreno, Javier ^a   Nieto, Javier ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIMONY DERIVATIVE; FLUCONAZOLE; INSECTICIDE; INTRALIPID; ITRACONAZOLE; KETOCONAZOLE; LEISHMANIA ANTIGEN; MEGLUMINE ANTIMONATE; METRONIDAZOLE; MILTEFOSINE; PARASITE ANTIGEN; PAROMOMYCIN; PENTAMIDINE; PREDNISOLONE; PREDNISONE; STIBOGLUCONATE SODIUM; UNCLASSIFIED DRUG; VACCINE;

AMASTIGOTE; ANOREXIA; ANTIBODY TITER; BREED; BULIMIA; CACHEXIA; CELLULAR IMMUNITY; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVITIS; COUGHING; DIARRHEA; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; DOG; DOG DISEASE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTAXIS; EXPERIMENTAL MODEL; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HOST; HOST PARASITE INTERACTION; HUMAN; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; LEISHMANIA CHAGASI; LEISHMANIA DONOVANI; LEISHMANIASIS; LYMPHADENOPATHY; NONHUMAN; PARASITE IDENTIFICATION; PARASITE VIRULENCE; POLYDIPSIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SERODIAGNOSIS; SKIN DEFECT; SOMNOLENCE; VISCERAL LEISHMANIASIS; WEIGHT REDUCTION;

ANIMALS; DOG DISEASES; DOGS; HUMANS; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL;

CANIS FAMILIARIS; LEISHMANIA DONOVANI; LEISHMANIA DONOVANI CHAGASI; LEISHMANIA INFANTUM; PHLEBOTOMINAE; PROTOZOA;

EID: 7044274161     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-308X(04)57001-X     Document Type: Review

References (284)

1. Abranches P., Lopes F.J., Fernandes P.S., Gomes L.T. Leishmaniasis in Portugal. I. Attemps to find a wild reservoir. Journal of Tropical Medicine and Hygiene. 85:1982;123-126
2. Abranches P., Conceiçao-Silva F.M., Ribeiro M.M., Lopes F.J., Gomes L.T. Kala-azar in Portugal - IV. The wild reservoir: the isolation of a Leishmania from a fox. Transactions of the Royal Society of Tropical Medicine and Hygiene. 77:1983;420-421
3. Abranches P., Conceicao-Silva F.M., Silva-Pereira M.C. Kala-azar in Portugal. V. The sylvatic cycle in the enzootic endemic focus of Arrabida. Journal of Tropical Medicine and Hygiene. 87:1984;197-200
4. Abranches P., Silva-Pereira M.C., Conceicao-Silva F.M., Santos-Gomes G.M., Janz J.G. Canine leishmaniasis: pathological and ecological factors influencing transmission of infection. Journal of Parasitology. 77:1991a;557-561
5. Abranches P., Santos-Gomes G., Rachamin N., Campino L., Schnur L., Jaffe C.L. An experimental model for canine visceral leishmaniasis. Parasite Immunolology. 13:1991b;537-550
6. Acedo-Sánchez C., Martín-Sánchez J., Vélez-Bernal I.D., Sanchís-Marín M.C., Louassini M., Maldonado J.A., Morillas-Marquez F. Leishmaniasis eco-epidemiology in the Alpujarra region (Granada Province, Southern Spain). International Journal for Parasitology. 25:1996;303-310
7. Acedo-Sánchez C., Morillas-Márquez F., Sanchís- Marín M.C., Martín-Sánchez J. Changes in antibody titres against Leishmania infantum in naturally infected dogs in southern Spain. Veterinary Parasitology. 75:1998;1-8
8. Adler S., Theodor O. Investigations on Mediterranean kala-azar. VI. Canine visceral leishmaniasis. Proceedings of the Royal Society, Series B. 110:1932;402-412
9. Aisa M.J., Castillejo S., Gállego M., Fisa R., Riera M.C., De Colmenares M., Torras S., Roura X., Sentis J., Portús M. Diagnostic potential of Western blot analysis of sera from dogs with leishmaniasis in endemic areas and significance of the pattern. American Journal of Tropical Medicine and Hygiene. 58:1998;154-159
10. Alexander B., Maroli M. Control of phlebotomine sandflies. Medical and Veterinary Entomology. 17:2003;1-18
11. Alexander B., Jaramillo C., Usma M.C., Quesada B.L., Cadena H., Roa W., Travi B.L. An attempt to control phlebotomine sand flies (Diptera: Psychodidae) by residual spraying with deltamethrin in a Colombian village. Memórias do Instituto Oswaldo Cruz. 90:1995a;421-424
12. Alexander B., Usma M.C., Cadena H., Quesada B.L., Solarte Y., Roa W., Travi B.L. Evaluation of deltamethrin-impregnated bednets and curtains against phlebotomine sandflies in Valle del Cauca, Colombia. Medical and Veterinary Entomology. 9:1995b;279-283
13. Al-Jaser M., El-Yazigi A., Croft S.L. Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis. Pharmaceutical Research. 12:1995;113-120
14. Altet L., Francino O., Solano-Gallego L., Renier C., Sánchez A. Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs. Infection and Immunity. 70:2002;2763-2771
15. Alvar, J. (2001). Las Leishmaniasis: de la Biología al Control. Salamanca: Laboratorios Intervet S.A
16. Alvar J., Molina R., San Andrés M., Tesouro M., Nieto J., Vitutia M., González F., San Andrés M.D., Boggio J., Rodríguez F., Sáinz A., Escacena C. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Annals of Tropical Medicine and Parasitology. 88:1994;371-378
17. Alvar J., Cañavate C., Gutiérrez-Solar B., Jiménez M., Laguna F., López-Vélez R., Molina R., Moreno J. Leishmania and human immunodeficiency virus coinfection: the first 10 years. Clinical Microbiology Reviews. 10:1997;298-319
18. Alving C.R. Liposomes as drug carriers in leishmaniasis and malaria. Parasitology Today. 2:1986;101-107
19. Amalraj D.D., Sivagnaname N., Srinivasan R. Susceptibility of Phlebotomus argentipes and P. papatasi (Diptera: Psychodidae) to insecticides. Journal of Communicable Diseases. 31:1999;177-180
20. Amela C., Méndez I., Torcal J.M., Medina G., Pachón I., Cañavate C., Alvar J. Epidemiology of canine leishmaniasis in the Madrid region, Spain. European Journal of Epidemiology. 11:1995;157-161
21. Amusátegui, I. (1998). Tratamiento de la leishmaniosis canina: valoración, caracterización y comparación de la respuesta a distintos protocolos a base de antimoniato de meglumina (asociado o no a alopurinol). Doctoral thesis, Departamento de Patología Animal II, Facultad de Veterinaria, Universidad Complutense de Madrid
22. Anam K., Afrin F., Banerjee D., Pramanik N., Guha S.K., Goswami R.P., Saha S.K., Ali N. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclass antibodies in Indian kala-azar patients after chemotherapy. Infection and Immunity. 67:1999;6663-6669
23. Andrade H.M., De Toledo V., Marques M.J., Franca Silva J.C., Tafuri W.L., Mayrink W., Genaro O. Leishmania (Leishmania) chagasi is not vertically transmitted in dogs. Veterinary Parasitology. 103:2002;71-81
24. Angel S.O., Requena J.M., Soto M., Criado D., Alonso C. During canine leishmaniasis a protein belonging to the 83-kDa heat-shock protein family elicits a strong humoral response. Acta Tropica. 62:1996;45-56
25. Anstead G.M., Chandrasekar B., Zhao W., Yang J., Perez L.E., Melby P.C. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection. Infection and Immunity. 69:2001;4709-4718
26. Ashford D.A., Bozza M., Freire M., Miranda J.C., Sherlock I., Eulalio C., Lopes U., Fernandes O., Degrave W., Barker R.H. jr, Badaro R., David J.R. Comparison of the polymerase chain reaction and serology for the detection of canine visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene. 53:1995;251-255
27. Ashford D.A., David J.R., Freire M., David R., Sherlock I., Eulalio M.C., Sampaio D.P., Badaro R. Studies on the control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil. American Journal of Tropical Medicine and Hygiene. 59:1998;53-57
28. Badaró R., Benson D., Eulálio M.C., Freire M., Cunha S., Netto E.M., Pedral-Sampaio D., Madureira C., Burns J.M., Houghton R.L., David J.R., Reed S.G. RK39: a cloned antigen of Leishmania chagasithat predicts active visceral leishmaniasis. Journal of Infectious Diseases. 173:1996;758-761
29. Baillie A.J., Coombs G.H., Dolan T.F., Laurie J. Non-ionic surfactant vesicles, niosomes, as a delivery system for the anti-leishmanial drug, sodium stibogluconate. Journal of Pharmaceutics and Pharmacology. 38:1986;502-505
30. Barwicz J., Gareau R., Audet A., Morisset A., Villiard J., Gruda I. Inhibition of the interaction between lipoproteins and amphotericin B by some delivery systems. Biochemical and Biophysical Research Communications. 181:1991;722-728
31. Benderitter T., Casanova P., Nashkidachvili L., Quilici M. Glomerulonephritis in dogs with canine leishmaniasis. Annals of Tropical Medicine and Parasitology. 82:1988;335-341
32. Berenguer A. Proposition d'une modalité particulière de traitement de la leishmaniose: canine guérison possible. Pratique Médicale et Chirurgicale de l'Animale de Compagnie. 23:1988;103-110. supplément 5
33. Bergeaud P. L'apport de la corticothérapie dans le traitement de certaines formes de leishmaniose canine: résultats sur une série de quarante-trois cas. Pratique Médicale et Chirurgicale de l'Animale de Compagnie. 23:1988;121-127. supplément 5
34. Berman J.D. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies. Reviews on Infectious Diseases. 10:1988;560-591
35. Berman J.D. Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clinical Infectious Diseases. 24:1997;684-703
36. Berman J.D., Gallalee J.V., Best J.M. Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid β-oxidation in Leishmania mexicana amastigotes. Biochemical Pharmacology. 36:1987;197-201
37. Berrahal F., Mary C., Roze M., Berenger A., Escoffier K., Lamouroux D., Dunan S. Canine leishmaniasis: identification of asymptomatic carriers by polymerase chain reaction and immunoblotting. American Journal of Tropical Medicine and Hygiene. 55:1996;273-277
38. Bettini S., Pozio E., Gradoni L. Leishmaniasis in Tuscany (Italy): (II) Leishmania from wild Rodentia and Carnivora in a human and canine leishmaniasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene. 74:1980;77-83
39. Boceta C., Alonso C., Jiménez-Ruiz A. Leucine rich repeats are the main epitopes in Leishmania infantum PSA during canine and human visceral leishmaniasis. Parasite Immunology. 22:2002;55-62
40. Borja-Cabrera G.P., Correia Pontes N.N., da Silva V.O., Paraguai de Souza E., Santos W.R., Gomes E.M., Luz K.G., Palatnik M., Palatnik de Sousa C.B. Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (São Goncalo do Amarante, RN). Vaccine. 20:2002;3277-3284
41. Bourdeau P., Groulade P. Results of an inquiry into leishmaniasis. Pratique Médicale et Chirurgicale de l'Animale de Compagnie. 23:1988;5-10. supplément 5
42. Bourdoiseau G., Bonnefont C., Magnol J.P., Saint-André I., Chabanne L. Lymphocyte subset abnormalities in canine leishmaniasis. Veterinary Immunology and Immunopathology. 56:1997a;345-351
43. Bourdoiseau G., Bonnefont C., Hoareau E., Boehringer C., Stolle T., Chabanne L. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs. Veterinary Immunology and Immunopathology. 59:1997b;21-30
44. Brajtburg J., Powderly W.G., Kobayashi G.S., Medoff G. Amphotericin B: current understanding of mechanisms of action. Antimicrobial Agents and Chemotherapy. 34:1990;183-188
45. Brandonisio O., Carelli G., Ceci L., Consenti B., Fasanella A., Puccini V. Canine leishmaniasis in the Gargano promontory (Apulia, South Italy). European Journal of Epidemiology. 8:1992;273-276
46. Brandonisio O., Panunzio M., Faliero S.M., Ceci L., Fasanella A., Puccini V. Evaluation of polymorphonuclear cell and monocyte functions in Leishmania infantum-infected dogs. Veterinary Immunology and Immunopathology. 53:1996;95-103
47. Brussieras J. Les thérapeutiques antileishmaniennes. L'Animal de Compagnie. 2:1977;137-141
48. Bunn-Moreno M.M., Madeira E.D., Miller K., Menezes J.A., Campos-Neto A. Hypergammaglobulinaemia in Leishmania donovani infected hamsters: possible association with a polyclonal activator of B cells and with suppression of T cell function. Clinical and Experimental Immunology. 59:1985;427-434
49. Buracco P., Abate O., Guglielmino R., Morello E. Osteomyelitis and arthrosynovitis associated with Leishmania donovani infection in a dog. Journal of Small Animal Practice. 38:1997;29-30
50. Burns J.M. jr, Shreffler W.G., Benson D.R., Ghalib H.W., Badaró R., Reed S.G. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proceedings of the National Academy of Sciences of the USA. 90:1993;775-779
51. Cabral M., O'Grady J., Alexander J. Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunology. 14:1992;531-539
52. Cabral M., O'Grady J.E., Gomes S., Sousa J.C., Thompson H., Alexander J. The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs. Veterinary Parasitology. 76:1998;173-180
53. Cardoso L., Neto F., Sousa J.C., Rodrigues M., Cabral M. Use of a leishmanin skin test in the detection of canine Leishmania-specific cellular immunity. Veterinary Parasitology. 79:1998;213-220
54. Carrera L., Fermín M.L., Tesouro M., García P., Rollán E., González J.L., Méndez S., Cuquerella M., Alunda J.M. Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers. Experimental Parasitology. 82:1996;139-146
55. Carter K.C., Baillie A.J., Alexander J., Dolan T.F. The therapeutic effect of sodium stibogluconate in BALB/c mice infected with Leishmania donovani is organ-dependent. Journal of Pharmaceutics and Pharmacology. 40:1988;370-373
56. Carvalho E.M., Bacellar O., Barral A., Badaró R., Johnson W.D. Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated. Journal of Clinical Investigation. 83:1989;860-864
57. Carvalho F.A.A., Charest H., Tavares C.A.P., Matlashewski G., Valente E.P., Rabello A., Gazzinelli R.T., Fernandes A.P. Diagnosis of American visceral leishmaniasis in humans and dogs using the recombinant Leishmania donovani A2 antigen. Diagnostic Microbiology and Infectious Diseases. 43:2002;289-295
58. Catarsini O. Epidemiology and clinical manifestations of canine leishmaniasis. Revista Parasitológica. 42:1981;83-87
59. Chamizo, C., Moreno, J. and Alvar, J. (in press). Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis. Veterinary Immunology and Immunopathology.
60. Chaniotis B. Current measures for the control of the phlebotomine sand flies and prevention of human disease. 1998;4-5 WHO Mediterranean Zoonoses Control Centre, information circular no. 45, Athens
61. Chaniotis B.N., Parsons R.E., Harlan H.J., Correa M.A. A pilot study to control phlebotomine sand flies (Diptera: Psychodidae) in a Neotropical rainforest. Journal of Medical Entomology. 19:1982;1-5
62. Chapman W.L., Hanson W.L., Alving C.R., Hendricks L.D. Antileishmanial activity of liposome-encapsulated meglumine antimonate in the dog. American Journal of Veterinary Research. 45:1984;1028-1032
63. Chatterjee M., Basu K., Basu D., Bannerjee D., Pramanik N., Guha S.K., Goswami R.P., Saha S.K., Mandal C. Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patients. Clinical and Experimental Immunology. 114:1998;408-413
64. Chicharro C., Morales M.A., Serra T., Ares M., Salas A., Alvar J. Molecular epidemiology of Leishmania infantum on the island of Majorca: a comparison of phenotypic and genotypic tools. Transactions of the Royal Society of Tropical Medicine and Hygiene. 96:2002;S1/93-S1/99. supplement 1
65. Chulay J.D., Anzeze E.M., Koech D.K., Bryceson D.M. High-dose sodium stibogluconate treatment of cutaneous leishmaniasis in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene. 77:1983;717-721
66. Chunge C.N., Gachihi G., Muigai R., Wassuna A., Rachid J.R., Chulay J.D., Anabwani G., Oster C.N., Bryceson D.M. Visceral leishmaniasis unresponsive to antimonial drugs III. Successful treatment using a combination of sodium stibogluconate plus allopurinol. Transactions of the Royal Society of Tropical Medicine and Hygiene. 79:1985;715-718
67. Collins M., Baillie J., Carter K.C. Visceral leishmaniasis in the BALB/c mouse: sodium stibogluconate treatment during acute and chronic stages of infection: II. Changes in tissue drug distribution. International Journal of Pharmaceutics. 83:1992;251-256
68. Corlouer J.P., Patat J.I., Spilbauer J.P. Case clinique: leishmaniose canine. Point Vétérinaire. 5:1983;75-76
69. Correia da Costa J.M., Neogy A.B., Vouldoukis I., Sampaio Silva M.L., Gentilini M., Monjour L. Antigenic components of partially purified antigens of Leishmania donovani infantum recognized by sera from dogs with asymptomatic or active visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene. 55:1996;511-515
70. Costa F.A., Guerra J.L., Silva S.M., Klein R.P., Mendonca I.L., Goto H. CD4(+) T cells participate in the nephropathy of canine visceral leishmaniasis. Brazilian Journal of Medical and Biological Research. 33:2000;1455-1458
71. Courtenay O., Quinnell R.J., Garcez L.M., Shaw J.J., Dye C. Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission. Journal of Infectious Diseases. 186:2002;1314-1320
72. Cruz I., Cañavate C., Rubio J.M., Morales M.A., Chicharro C., Laguna F., Jiménez-Mejías M., Sirera G., Videla S., Alvar J. Spanish HIV-Leishmania Study Group. A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus. Transactions of the Royal Society of Tropical Medicine and Hygiene. 96:2002;S1/185-S1/189. supplement 1
73. Da Silva V.O., Borja-Cabrera G.P., Correia Pontes N.N., de Souza E.P., Luz K.G., Palatnik M., Palatnik de Sousa C.B. A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (São Goncalo do Amaranto, RN). Vaccine. 19:2002;1082-1092
74. David J.R., Stamm L.M., Bezerra H.S., Suza R.N., Killick-Kendrick R., Oliveira-Lima J.W. Deltamethrin-impregnated dog collars have a potent anti-feeding and insecticidal effect on Lutzomyia longipalpis and Lutzomyia migonei. Memórias do Instituto Oswaldo Cruz. 96:2001;839-847
75. De Luna R., Vuotto M.L., Ielpo M.T., Ambrosio R., Piantedosi D., Moscatiello V., Ciaramella P., Scalone A., Gradoni L., Mancino D. Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum. Veterinary Immunology and Immunopathology. 70:1999;95-103
76. Denerolle P. Leishmaniose canine: difficultés du diagnostic et du traitement (125 cas). Pratique Médicale et Chirurgicale de l'Animale de Compagnie. 31:1996;137-145
77. Deplazes P., Smith N.C., Arnold P., Lutz H., Eckert J. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Parasite Immunology. 17:1995;451-458
78. Dereure J., Rioux J.A., Khiami A., Pratlong F., Perières J., Martini A. Ecoepidemiology of leishmaniases in Syria. 2 - Presence, in dogs, of Leishmania infantum (Nicolle) and Leishmania tropica (Wright) (Kinetoplastida-Trypanosomatidae). Annales de Parasitologie Humaine et Comparée. 66:1991;252-255
79. Desjeux, P. (1991). Information on the epidemiology and control of leishmaniasis by country and territory. Geneva: World Health Organization, mimeographed document WHO/LEISH/91.30
80. Desjeux P. Leishmaniasis: public health aspects and control. Clinics in Dermatology. 14:1996;417-423
81. Díaz-Espineira M.M., Slappendel R.J. A case of autochthonous canine leishmaniasis in The Netherlands. Veterinary Quarterly. 19:1997;69-71
82. Dunan S. Interpretation des résultats biologiques dans les leishmanioses humaines et canines. Recueil Médicale et Vétérinaire. 154:1978;251-261
83. Dunan S., Frommel D., Monjour L., Ogunkolade B.W., Cruz A., Quilici M. Vaccination trial against canine visceral leishmaniasis. Parasite Immunology. 11:1989;397-402
84. Dye C. The logic of leishmaniasis control. American Journal of Tropical Medicine and Hygiene. 55:1996;125-130
85. Elbihari S., Cheema A.H., El-Hassan A.M. Leishmania infecting man and wild animals in Saudi Arabia. Canine cutaneous leishmaniasis in the Eastern Province. Transactions of the Royal Society of Tropical Medicine and Hygiene. 81:1987;925-927
86. El Harith A., Slappendel R.J., Reiter I., Van Knapen F., De Korte P., Huigen E., Kolk A.H.J. Application of a direct agglutination test for detection of specific anti-Leishmania antibodies in the canine reservoir. Journal of Clinical Microbiology. 27:1989;2252-2257
87. Elnaiem D.A., Elnahas A.M., Aboud M.A. Protective efficacy of lambda-cyhalothrin-impregnated bednets against Phlebotomus orientalis, the vector of visceral leishmaniasis in Sudan. Medical and Veterinary Entomology. 13:1999;310-314
88. Eshita Y., Gómez E.A., Hashiguchi Y. A brief note on application of insecticides for the control of endophilic sandflies. Hashiguchi Y. Studies on New World Leishmaniasis and its Transmission with Particular Reference to Ecuador. 1994;51-55 Kyowa Printing Co. Ltd, Kochi City, Japan
89. Euzeby J. Thérapeutique de la leishmaniose générale du chien. Actualité-Perspectives. Revue de Médecine Vétérinaire. 133:1982;383-390
90. Euzeby J. Leishmaniose canine. Thérapeutique actuelle et nouveaux concepts. Pratique Médicale et Chirurgicale de l'Animale de Compagnie. 23:1988;103-110. supplément 5
91. Fernández-Pérez F.J., Méndez S., de la Fuente C., Cuquerella M., Gómez M.T., Alunda J.M. Value of Western blotting in the clinical follow-up of canine leishmaniasis. Journal of Veterinary Diagnostic Investigation. 11:1999;170-173
92. Ferrer L. Leishmaniosis canina en España: datos para el clínico. Enfermedades Infecciosas y Microbiología Clinica. 7:1989;293-295
93. Ferrer L. Leishmaniasis. Kirk R.W., Bonagura J.D. Kirk's Current Veterinary Therapy. 1992;879-885 W.B. Saunders, Philadelphia
94. Ferrer L., Rabanal R., Fondevila D., Ramos J.A., Domingo M. Skin lesions in canine leishmaniasis. Journal of Small Animal Practice. 29:1988;381-388
95. Ferrer L., Aisa M.J., Roura X., Portús M. Serological diagnosis and treatment of canine leishmaniasis. Veterinary Record. 136:1995;514-516
96. Fielding R.M. Liposomal drug delivery. Clinical Pharmacokinetics. 21:1991;155-164
97. Fielding R.M., Singer A.W., Wang L.H., Barbar S., Guo L.S. Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogs. Antimicrobial Agents and Chemotherapy. 36:1992;299-307
98. Fisa R., Gállego M., Castillejo S., Aisa M.J., Serra T., Riera C., Carrio J., Gállego J., Portús M. Epidemiology of canine leishmaniosis in Catalonia (Spain): the example of the Priorat focus. Veterinary Parasitology. 83:1999;87-97
99. Fisa R., Riera C., Gállego M., Manubens J., Portús M. Nested PCR for diagnosis of canine leishmaniosis in peripheral blood, lymph node and bone marrow aspirates. Veterinary Parasitology. 99:2001;105-111
100. Fondevila D., Vilafranca M., Ferrer L. Epidermal immunocompetence in canine leishmaniasis. Veterinary Immunology and Immunopathology. 56:1997;319-327
101. Font A., Roura X., Fondevila D., Closa J.M., Mascort J., Ferrer L. Canine mucosal leishmaniasis. Journal of the American Animal Hospital Association. 32:1996;131-137
102. Gaeta G.B., Gradoni L., Gramiccia M., Martino L., Pizzuti R., Pempinello R., Scotti S., Maisto A. Leishmaniosi viscerale in Italia. Epidemiologia, clinica, terapia. Recenti Progressi di Medicina. 85:1994;340-347
103. Galvao-Castro B., Sa Ferreira J.A., Marzochi K.F., Marzochi M.C., Coutinho S.G., Lambert P.H. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clinical and Experimental Immunology. 56:1984;58-66
104. García-Alonso M., Nieto C.G., Blanco A., Requena J.M., Alonso C., Navarrete I. Presence of antibodies in the aqueous humour and cerebrospinal fluid during Leishmania infections in dogs. Pathological features of the central nervous system. Parasite Immunology. 18:1996;539-546
105. Gaskin A.A., Schantz P., Jackson J., Birkenheuer A., Tomlinson L., Gramiccia M., Levy M., Steurer F., Kollmar E., Hegarty B.C., Ahn A., Breitschwerdt E.B. Visceral leishmaniasis in a New York foxhound kennel. Journal of Veterinary Internal Medicine. 16:2002;34-44
106. Gebre-Hiwot A., Tadesse G., Croft S.L., Frommel D. An in vitro model for screening antileishmanial drugs: the human leukemia monocyte cell line THP-1. Acta Tropica. 51:1992;237-245
107. Giger U., Oakley D.A., Owens S.D., Schantz P. Leishmania donovani transmission by packed RBC transfusion to anemic dogs in the United States. Transfusion. 42:2002;381-383
108. Gigliotti F., Sheneo J.L., Lott L., Thornton D. Induction of prostaglandin synthesis as the mechanism responsible for the chills and fever produced by infusing amphotericin. British Journal of Infectious Disesases. 156:1987;784-789
109. Ginel P.J., Lucena R., Lopez R., Molleda M. Use of allopurinol for maintenance of remission in dogs with leishmaniosis. Journal of Small Animal Practice. 39:1998;271-274
110. Goad L., Holz G.G. jr, Beach D.H. Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes. Molecular and Biochemical Parasitology. 15:1985;257-279
111. Gómez-Nieto, I.C. (1990). Epidemiología y clínica de la leishmaniosis canina en Cáceres. Doctoral thesis, Facultad de Veterinaria, Universidad de Extremadura
112. Gradoni L. An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine. Veterinary Parasitology. 100:2001;87-103
113. Gradoni L., Pozio E., Bettini S., Gramiccia M. Leishmaniasis in Tuscany (Italy) III. The prevalence of canine leishmaniasis in two foci of Grosseto Province. Transactions of the Royal Society of Tropical Medicine and Hygiene. 74:1980;421-422
114. Gradoni L., Maroli M., Gramiccia M., Mancianti F. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment. Medical and Veterinary Entomology. 1:1987;339-342
115. Gradoni L., Gramiccia M., Mancianti F., Pieri S. Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy. Transactions of the Royal Society of Tropical Medicine and Hygiene. 82:1988;568-571
116. Gramiccia M., Gradoni L., Orsini S. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Annals of Tropical Medicine and Parasitology. 86:1992;613-620
117. Griffiths W.A.D. Old World cutaneous leishmaniosis. Peters W., Killick-Kendrick R. The Leishmaniases in Biology and Medicine. 2:1987;617-636 Academic Press, London
118. Guanghua X, Changfa J, Xinzhong C, Zyhongwei S, Yumei H. [Deltamethrin bath of domestic dog in the prevention of sand fly bite]. Endemic Disease Bulletin. 9:1994;32-34.. [In Chinese; cited by Reithinger et al., 2001.]
119. Guarga J.L., Lucientes J., Peribáñez M.A., Molina R., Gracia M.J., Castillo J.A. Experimental infection of Phlebotomus perniciosus and determination of the natural infection rates of Leishmania infantum in dogs. Acta Tropica. 77:2000a;203-207
120. Guarga J.L., Moreno J., Lucientes J., Gracia M.J., Peribáñez M.A., Alvar J., Castillo J.A. Canine leishmaniasis transmission: higher infectivity amongst naturally infected dogs to sand flies is associated with lower proportions of T helper cells. Research in Veterinary Science. 69:2000b;249-253
121. Guarga J.L., Moreno J., Lucientes J., Gracia M.J., Peribáñez M.A., Castillo J.A. Evaluation of a specific immunochemotherapy for the treatment of canine visceral leishmaniasis. Veterinary Immunology and Immunopathology. 88:2002;13-20
122. Guillén Llera J.L., López García M.L., Martín Reinoso E., De Vivar González R. Differential serological testing by simultaneous indirect immunofluorescent antibody test in canine leishmaniosis and ehrlichiosis. Veterinary Parasitology. 109:2002;185-190
123. Halbig P., Hodjati M.H., Mazloumi-Gavgani A.S., Mohite H., Davies C.R. Further evidence that deltamethrin-impregnated collars protect domestic dogs from sandfly bites. Medical and Veterinary Entomology. 14:2000;223-226
124. Handman E. Leishmaniasis: current status of vaccine development. Clinical Microbiology Reviews. 14:2001;229-243
125. Harrison L.H., Naidu T.G., Dew J.S., de Alencar J.E., Pearson R.D. Reciprocal relationships between undernutrition and the parasitic disease visceral leishmaniasis. Reviews on Infectious Diseases. 8:1986;447-453
126. Headington C.E., Barbara C.H., Lambson B.E., Hart D.T., Barker D.C. Diagnosis of leishmaniasis in Maltese dogs with the aid of the polymerase chain reaction. Transactions of the Royal Society of Tropical Medicine and Hygiene. 96:2002;S1/195-S1/197. supplement 1
127. Hentzer B., Kobayasi T. The ultrastructural changes of Leishmania tropica after treatment with pentamidine. Annals of Tropical Medicine and Parasitology. 71:1977;157-166
128. Hernández-Rodríguez, S.R., Gómez-Nieto, C. Martínez-Gómez, F. and Gutiérrez-Palomino, P. (1987). Aspectos clínicos de la leishmaniosis canina. Revista Ibérica de Parasitología, volumen extraordinario, pp. 61-66
129. Hervás Rodríguez J., Mozos E., Méndez A., Pérez J., Gómez-Villamandos J.C. Leishmania infection of canine skin fibroblasts in vivo. Veterinary Pathology. 33:1996;469-473
130. Hiemenz J.W., Walsh T.J. Lipid formulations of amphptericin B: recent progress and future directions. Clinical Infectious Diseases. 22:1996;133-144. supplement 2
131. Jambou D., Marty P., Jambou R., Le Fichoux Y., Haas P., Jourdain N., Bayada M. Preliminary serological study on canine leishmaniasis in the Alpes-Maritimes Departement, France. Transactions of the Royal Society of Tropical Medicine and Hygiene. 80:1986;666-667
132. Jha T.K., Sundar S., Thakur C.P., Bachman P., Karbwang J., Fisher C., Voss A., Berman J. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. New England Journal of Medicine. 341:1999;1795-1800
133. Joshi G.C., Kaul S.M., Wattal G.L. Susceptibility of sandflies to organochlorine insecticides in Bihar (India) - further reports. Journal of Communicable Diseases. 11:1979;209-213
134. Kane M.M., Mosser D.M. The role of IL-10 in promoting disease progression in leishmaniasis. Journal of Immunology. 166:2001;1141-1147
135. Karp C.L., El-Safi S.H., Wynn T.A., Satti M.M., Kordofani A.M., Hashim F.A., Hag-Ali M., Neva F.A., Nutman T.B., Sacks D.L. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. Journal of Clinical Investigation. 91:1993;1644-1648
136. Kassem H.A., Tewfick M.K., El Sawaf B.M. Evaluation of avermectins as sandfly control agents. Annals of Tropical Medicine and Parasitology. 95:2001;405-411
137. Keenan C.M., Hendricks L.D., Lightner L., Webster H.K., Johnson A.J. Visceral leishmaniasis in the German Shepherd dog. I. Infection, clinical disease, and clinical pathology. Veterinary Pathology. 21:1984a;74-79
138. Keenan C.M., Hendricks L.D., Lightner L., Johnson A.J. Visceral leishmaniasis in the German Shepherd dog. II. Pathology. Veterinary Pathology. 21:1984b;80-86
139. Kelly D.W., Mustafa Z., Dye C. Differential application of lambda-cyhalothrin to control the sandfly Lutzomyia longipalpis. Medical and Veterinary Entomology. 11:1997;13-24
140. Kenney R.T., Sacks D.L., Gam A.A., Murray H.W., Sundar S. Splenic cytokine responses in Indian kala-azar before and after treatment. Journal of Infectious Diseases. 177:1998;815-818
141. Killick-Kendrick R. The biology and control of phlebotomine sandflies. Clinics in Dermatology. 17:1999a;279-289
142. Killick-Kendrick R. Anti-feeding effects of synthetic pyrethroids against phlebotomine sand flies and mosquitoes and the prospects of controlling canine leishmaniasis with deltamethrin-impregnated ProtectorBands (Scalibor®). Killick-Kendrick R. Canine Leishmaniasis: an update. 1999b;82-88 Hoechst Roussel Vet, Barcelona
143. Killick-Kendrick R., Killick-Kendrick M., Focheux C., Dereure J., Puech M.P., Cadiergues M.C. Protection of dogs from bites of phlebotomine sandflies by deltamethrin collars for control of canine leishmaniasis. Medical and Veterinary Entomology. 11:1997;105-111
144. Koutinas A.F., Saridomichelakis M.N., Mylonakis M.E., Leontides L., Polizopoulou Z., Billinis C., Argyriadis D., Diakou N., Papadopoulos O. A randomized, blinded, placebo-controlled clinical trial with allopurinol in canine leishmaniasis. Veterinary Parasitolology. 98:2001;247-261
145. Kuhlencord A., Maniera T., Eibl H., Unger C. Hexadecylphosphocholine: oral treatment of visceral leishmaniasis in mice. Antimicrobial Agents and Chemotherapy. 36:1992;1630-1634
146. Lachaud L., Chabbert E., Dubessay P., Dereure J., Lamothe J., Dedet J.P., Bastien P. Value of two PCR methods for the diagnosis of canine visceral
147. Lamothe J. Essai de traitment de la leishmaniose canine par l'amphotéricine B (39 cas). Pratique Médicale et Chirurgicale de l'Animale de Compagnie. 32:1997;133-141
148. Lanotte G., Rioux J.A., Perieres J., Vollhardt Y. Ecologie des leishmanioses dans le sud de la France. 10. Les formes évolutives de la leishmaniose viscérale canine. Elaboration d'une typologie bio-clinique à finalité épidémiologique. Annales de Parasitologie Humaine et Comparée. 54:1979;277-295
149. Lasri S., Sahibi H., Sadak A., Jaffe C.L., Rhalem A. Immune response in vaccinated dogs with autoclaved Leishmania major promastigotes. Veterinary Research. 30:1999;441-449
150. Leandro C., Santos-Gomes G.M., Campino L., Romao P., Cortes S., Rolao N., Gomes-Pereira S., Rica Capela M.J., Abranches P. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis. Veterinary Immunology and Immunopathology. 79:2001;273-284
151. Le Fichoux Y., Rousseau D., Ferrua B., Ruette S., Lelievre A., Grousson D., Kubar J. Short- and long-term efficacy of hexadecylphosphocholine against established Leishmania infantum infection in Balb/c mice. Antimicrobial Agents and Chemotherapy. 42:1998;654-658
152. Legrand P., Romero E.A., Cohen B.E., Bolard J. Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes. Antimicrobial Agents and Chemotherapy. 36:1992;2518-2522
153. Liew F.Y., O'Donnell C.A. Immunology of leishmaniasis. Advances in Parasitology. 32:1993;161-259
154. Longstaffe J.A., Guy M.W. Canine leishmaniasis: United Kingdom update. Journal of Small Animal Practice. 27:1986;663-667
155. Looker D.L., Marr J.J., Berens R.L. Mechanisms of action of pyrazolopyrimidines in Leishmania donovani. Journal of Biological Chemistry. 261:1986;9412-9415
156. López R., Lucena R., Novales M., Ginel P.J., Martín E., Molleda J.M. Circulating immune complexes and renal function in canine leishmaniasis. Zentralblatt von Veterinärmedizin. 43:1996;469-474
157. Lucena R., Molleda J.M., Ginel P.J., Novales M., Martín E., López R. Third component of complement serum levels in dogs with leishmaniasis. Zentralblatt von Veterinärmedizin. 41:1994;48-52
158. Lucientes J. Laboratory observations on the protection of dogs from the bites of Phlebotomus perniciosus with Scalibor® ProtectorBands: preliminary results. Killick-Kendrick R. Canine Leishmaniasis: an update. 1999;92-94 Hoechst Roussel Vet, Barcelona
159. Maddux M.S., Barriere S.L. A review of complications of amphotericin-B therapy: recommendations for prevention and management. Drug Intelligence and Clinical Pharmacy. 14:1980;177-195
160. Majori G., Maroli M., Sabatinelli G., Fausto A.M. Efficacy of permethrin-impregnated curtains against endophilic phlebotomine sandflies in Burkina Faso. Medical and Veterinary Entomology. 3:1989;441-444
161. Makni S., Ayed K., Ben Said M., Ben Rachid M.S. Study of circulating immune complexes during the evolution of visceral Mediterranean leishmaniasis. Annals of Tropical Medicine and Parasitology. 83:1989;349-355
162. Malik R. Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin. Australian Veterinary Journal. 73:1996;124-128
163. Mancianti F., Sozzi S. Isolation of Leishmania from a newborn puppy. Transactions of the Royal Society of Tropical Medicine and Hygiene. 89:1995;402
164. Mancianti F., Gradoni I., Gramiccia M., Pieri S., Marconcini A. Canine leishmaniasis in the isle of Elba, Italy. Tropical Medicine and Parasitology. 37:1986;110-112
165. Mancianti F., Gramiccia M., Gradoni L., Pieri S. Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene. 82:1988;566-567
166. Mancianti F., Poli A., Bionda A. Analysis of renal immune-deposits in canine leishmaniasis. Preliminary results. Parassitologia. 31:1989;213-230
167. Mancianti F., Mignone W., Galastri F. Serologic survey for leishmaniasis in free-living red foxes (Vulpes vulpes) in Italy. Journal of Wild Life Diseases. 30:1994;454-456
168. Mancianti F., Pedonese F., Poli A. Evaluation of dot enzyme-linked immunosorbent assay (dot-ELISA) for the serodiagnosis of canine leishmaniasis as compared with indirect immunofluorescence assay. Veterinary Parasitology. 65:1996;1-9
169. Maroli M., Majori G. Permethrin-impregnated curtains against phlebotomine sandflies (Diptera: Psychodidae): laboratory and field studies. Parassitologia. 33:1991;399-404. supplemento
170. Maroli M., Mizzoni V., Siragusa C., D'Orazi A., Gradoni L. Evidence for an impact on the incidence of canine leishmanisais by the mass use of deltamethrin-impregnated dog collars in southern Italy. Medical and Veterinary Entomology. 15:2001;358-363
171. Martínez-Moreno A., Martínez-Cruz M.S., Blanco A., Hernández-Rodriguez S. Immunological and histological study of T- and B-lymphocyte activity in canine visceral leishmaniosis. Veterinary Parasitology. 51:1993;49-59
172. Martín-Luengo F., Quiles J. La leishmaniasis en España. Revista de Sanidad e Higiene Pública. 56:1982;699-726
173. Marzochi M.C., Coutinho S.G., De Souza W.J., De Toledo L.M., Grimaldi G., Momen H., Pacheco R.S., Sabroza P.C., De Souza M.A., Rangel F.B., Tramontano N.C. Canine visceral leishmaniasis in Rio de Janeiro, Brazil. Clinical, parasitological, therapeutical and epidemiological findings (1977-1983). Memórias do Instituto Oswaldo Cruz. 80:1985;349-357
174. Mathis A., Deplazes P. PCR and in vitro cultivation for detection of Leishmania spp. in diagnostic samples from humans and dogs. Journal of Clinical Microbiology. 33:1995;1145-1149
175. Mayrink W., Genaro O., Silva J.C., da Costa R.T., Tafuri W.L., Toledo V.P., da Silva A.R., Reis A.B., Williams P., da Costa P.W. Phases I and II open clinical trials of a vaccine against Leishmania chagasi in dogs. Memórias do Instituto Oswaldo Cruz. 91:1996;695-697
176. Mazloumi-Gavgani A.S., Hodjati M.H., Mohite H., Davies C.R. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet. 369:2002;374-379
177. Miles M.A., Vexenat J.A., Furtado Campos J.H., Fonseca de Castro J.A. Canine leishmaniasis in Latin America: control strategies for visceral leishmaniasis. Killick-Kendrick R. Canine Leishmaniasis: an update. 1999;46-53 Hoechst Roussel Vet, Barcelona
178. Miralles G.D., Stoeckle M.Y., McDermott D.F., Finkelman F.D., Murray H.W. Th1 and Th2 cell-associated cytokines in experimental visceral leishmaniasis. Infection and Immunity. 62:1994;1058-1063
179. Mohebali M., Fallah E., Jamshidi S., Hajjaran H. Vaccine trial against canine visceral leishmaniasis in the Islamic Republic of Iran. Revue de la Santé Mediterranée Orientale. 4:1998;234-238
180. Molano I., Alonso García M., Mirón C., Redondo E., Requena J.M., Soto M., Nieto C.G., Alonso C. A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum. Veterinary Immunology and Immunopathology. 92:2003;1-13
181. Molina R., Amela C., Nieto J., San-Andrés M., González F., Castillo J.A., Lucientes J., Alvar J. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88:1994;491-493
182. Molina R., Lohse J.M., Pulido F., Laguna F., López-Vélez R., Alvar J. Infection of sand flies by humans coinfected with Leishmania infantum and human immunodeficiency virus. American Journal of Tropical Medicine and Hygiene. 60:1999;51-53
183. Molina R., Lohse J.M., Nieto J. Evaluation of a topical solution containing 65% permethrin against the sandfly (Phlebotomus perniciosus) in dogs. Veterinary Therapeutics. 2:2001;261-267
184. Molyneux D.H., Ashford R.W. The Biology of Trypanosoma and Leishmania, Parasites of Man and Animals. 1983;Taylor & Francis, London
185. Morales G., Carrillo G., Requena J.M., Guzmán F., Gómez L.C., Patarroyo M.E., Alonso C. Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis. Parasitology. 114:1997;507-516
186. Moreno J., Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends in Parasitology. 18:2002;399-405
187. Moreno J., Nieto J., Chamizo C., González F., Blanco F., Barker D.C., Alvar J. The immune response and PBMC subsets in canine visceral leishmaniasis before and after chemotherapy. Veterinary Immunology. 71:1999;181-195
188. Morillas F., Benavides I., González J., Reyes A., Valero A. Dècouverte de Leishmania sp. dans le Rattus rattus de la province de Grènade (Espagne). Annales de Parasitologie Humaine et Comparée. 60:1985;768-770
189. Morillas F., Sánchez-Rabasco F., Ocaña J., Martín-Sánchez J., Ocaña-Wihelmi J., Acedo C., Sanchíz-Marín M.C. Leishmaniosis in the focus of the Axarquia region, Málaga province, southern Spain: a survey of the human, dog, and vector. Parasitology Research. 82:1996;569-570
190. Mottram J.C., Coombs G.H. Leishmania mexicana: enzyme activities of amastigotes and promastigotes and their inhibition by antimonials and arsenicals. Experimental Parasitology. 59:1985;151-160
191. Nascimento M.D., Costa J.M., Fiori B.I., Viana G.M., Filho M.S., Alvim A.C., Bastos O.C., Nakatani M., Reed S., Badaro R., da Silva A.R., Burattini M.N. The epidemiological determinant aspects in the maintenance of visceral leishmaniasis in the state of Maranhao, Brazil. Revista da Sociedade Brasileira de Medicina Tropical. 29:1996;233-240
192. Neal R.A., Murphy A.G., Olliaro P., Croft S.L. Aminosidine ointments for the treatment of experimental cutaneous leishmaniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene. 88:1994;223-225
193. Neogy A.B., Vouldoukis J., Costa J.M., Monjour L. Exploitation of parasite-derived antigen in therapeutic success against canine visceral leishmaniosis. Veterinary Parasitology. 54:1994;367-373
194. Nieto C.G., Navarrete I., Habela M.A., Serrano F., Redondo E. Pathological changes in kidneys of dogs with natural Leishmania infection. Veterinary Parasitology. 45:1992;33-47
195. Nieto C.E., García-Alonso M., Requena J.M., Mirón C., Soto M., Alonso C., Navarrete I. Analysis of the humoral immune response against total and recombinant antigens of Leishmania infantum: correlation with disease progression in canine experimental leishmaniasis. Veterinary Immunology and Immunopathology. 67:1999;117-130
196. Nieto J., Alvar J., Mullen A.B., Carter K.C., Rodríguez C., San Andrés M.I., San Andrés M.D., Baillie A.J., González F. A comparison of the pharmacokinetics, toxicity and efficacy of different sodium stibogluconate formulations after intravenous administration in animals. Antimicrobial Agents and Chemotherapy. 47:2003;2781-2787
197. Oliva G., Gradoni L., Cianarmella P., De Luna R., Cortese L., Orsini S., Davidson R.N., Persechino A. Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum. Journal of Antimicrobial Chemotherapy. 36:1995;1013-1019
198. Oliva G., Gradoni L., Cortese L., Orsini S., Ciaramella P., Scalone A., de Luna R., Persechino A. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis. Annals of Tropical Medicine and Parasitology. 92:1998;165-171
199. Oliveira G.G., Santoro F., Sadigursky M. The subclinical form of experimental visceral leishmaniasis in dogs. Memórias do Instituto Oswaldo Cruz. 88:1993;243-248
200. Olliaro P.L., Bryceson A.D.M. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitology Today. 9:1993;323-328
201. Owens S.D., Oakley D.A., Maryott K., Hatchett W., Walton R., Nolan T.J., Newton A., Steurer F., Schnatz P., Giger U. Transmission of visceral leishmaniasis to anemic dogs through blood transfusions from infected foxhounds. Journal of the American Veterinary Medical Association. 219:2001;1076-1083
202. Ozbel Y., Oskam L., Ozensoy S., Turgay N., Alkan M.Z., Jaffe C.L., Ozcel M.A. A survey on canine leishmaniasis in western Turkey by parasite, DNA and antibody detection assays. Acta Tropica. 74:2000;1-6
203. Ozensoy S., Ozbel Y., Turgay N., Alkan M.Z., Gul K., Gilman-Sachs A., Chang K.P., Reed S.G., Ozcel M.A. Serodiagnosis and epidemiology of visceral leishmaniasis in Turkey. American Journal of Tropical Medicine and Hygiene. 59:1998;363-369
204. Pal A., Agarwal A., Guru P.Y., Katiyar J.C. Enhanced efficacy of liposomised pentamidine against experimental visceral leishmaniasis. Journal of Parasitological Diseases. 19:1995;45-48
205. Parrot L., Donatien A., Lestoquard F. Sur le développement du parasite du leishmaniose canine viscérale chez Phlebotomus major var. perniciosus Newstead. Bulletin de la Société de Pathologie Exotique. 23:1930;724-726
206. Persechino A., Oliva G. Autoimmunity associated with leishmaniasis in dogs. Acta Medica Veterinaria. 32:1986;117-124
207. Peters W., Elbihari S., Evans D.A. Leishmania infecting man and wild animals in Saudi Arabia. 2. Leishmania arabica n. sp. Transactions of the Royal Society of Tropical Medicine and Hygiene. 80:1986;497-502
208. Pinelli E., Killick-Kendrick R., Wagenaar J., Bernadina W., del Real G., Ruitenberg E.J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infection and Immunity. 62:1994;229-235
209. Pinelli E., Gonzalo R.M., Boog C.J., Rutten V.P., Gebhard D., del Real G., Ruitenberg E.J. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner. European Journal of Immunology. 25:1995;1594-1600
210. Pinelli E., van der Kaaij S.Y., Slappendel R., Fragio C., Ruitenberg E.J., Bernadina W., Rutten V.P. Detection of canine cytokine gene expression by reverse transcription-polymerase chain reaction. Veterinary Immunology and Immunopathology. 69:1999;121-126
211. Poli A., Sozzi S., Guidi G., Bandinelli P., Mancianti F. Comparison of aminosidine (paromomycin) and sodium stibogluconate for treatment of canine leishmaniasis. Veterinary Parasitology. 71:1997;263-271
212. Portús M., Fisa R., Serra T., Gállego M., Mora M. Estudios seroepidemiológicos sobre la leishmaniosis canina en Cataluña. Medicina Veterinaria. 4:1987;469-575
213. Pozio E., Gradoni L., Bettini S., Gramiccia M. Leishmaniasis in Tuscany (Italy): VI. Canine leishmaniasis in the focus of Monte Argentario (Grosseto). Acta Tropica. 38:1981;383-393
214. Pumarola M., Brevik L., Badiola J., Vargas A., Domingo M., Ferrer L. Canine leishmaniasis associated with systemic vasculitis in two dogs. Journal of Comparative Pathology. 105:1991;279-286
215. Quijada L., Requena J.M., Soto M., Alonso C. During canine viscero-cutaneous leishmaniasis the anti-Hsp70 antibodies are specifically elicited by the parasite protein. Parasitology. 112:1996;277-284
216. Quinnell R.J., Courtenay O., Davidson S., Garcez L., Lambson B., Ramos P., Shaw J.J., Shaw M.A., Dye C. Detection of Leishmania infantum by PCR, serology and cellular immune response in a cohort study of Brazilian dogs. Parasitology. 122:2001a;253-261
217. Quinnell R.J., Courtenay O., Shaw M.A., Day M.J., Garcez L.M., Dye C., Kaye P.M. Tissue cytokine responses in canine visceral leishmaniasis. Journal of Infectious Diseases. 183:2001b;1421-1424
218. Quinnell R.J., Courtenay O., Garcez L.M., Kaye P.M., Shaw M.A., Dye C., Day M.J. IgG subclass responses in a longitudinal study of canine visceral lesihmaniasis. Veterinary Immunology and Immunopathology. 91:2003;161-168
219. Rachamim N., Jaffe C.L., Abranches P., Silva-Pereira M.C.D., Schnur L.F., Jacobson R.L. Serodiagnosis of canine visceral leishmaniasis in Portugal: comparison of three methods. Annals of Tropical Medicine and Parasitology. 85:1991;503-508
220. Ramiro M.J., Zárate J.J., Hanke T., Rodríguez D., Rodríguez J.R., Esteban M., Lucientes J., Castillo J.A., Larraga V. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine. 21:2003;2474-2484
221. Reale S., Maxia L., Vitale F., Glorioso N.S., Caraccapa S., Vesco G. Detection of Leishmania infantum in dogs by PCR with lymph node aspirates and blood. Journal of Clinical Microbiology. 37:1999;2931-2935
222. Reithinger R., Teodoro U., Davies C.R. Topical insecticide treatments to protect dogs from sand fly vectors of leishmaniasis. Emerging Infectious Diseases. 7:2001;872-876
223. Reithinger R., Quinnell R.J., Alexander B., Davies C.L. Rapid detection of Leishmania infantum infection in dogs: comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR. Journal of Clinical Microbiology. 40:2002;2352-2356
224. Rhalem A., Sahibi H., Idrissi Guessous-N., Lasri S., Natami A., Riyad M., Berrag B. Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum. Veterinary Parasitology. 81:1999;173-184
225. Riera C., Valladares J.E. Viable Leishmania infantum in urine and semen in experimentally infected dogs. Parasitology Today. 12:1996;412
226. Rioux J.A., Albaret J.L., Houin R., Dedet J.P., Lanotte G. Écologie des leishmanioses dans le sud de la France. 2. Les réservoires selvatiques. Infestation spontanée du renard (Vulpes vulpes L.). Annales de Parasitologie Humaine et Comparée. 43:1968;421-428
227. Rioux J.A., Lanotte G., Croset H., Dedet J.P. Écologie des leishmanioses dans le sud de la France. 5. Pouvoir infestant comparé des diverses formes de leishmanioses canine vis-à-vis de Phlebotomus ariasi Tonnoir, 1921. Annales de Parasitologie Humaine et Comparée. 47:1972;413-419
228. Rioux J.A., Killick-Kendrick R., Leaney A.J., Turner D.P., Bailly M., Young C.J. Écologie des leishmanioses dans le sud de la France. 11. La leishmaniose viscérale canine: succes de la transmission expérimentale chien-phlébotome-chien par la piqûre de Phlebotomus ariasi Tonnoir 1921. Annales de Parasitologie Humaine et Comparée. 54:1979;401-407
229. Rolland L., Zilberfarb V., Furtado A., Gentilini M. Identification of a 94-kilodalton antigen on Leishmania promastigotes forms and its specific recognition in human and canine visceral leishmaniasis. Parasite Immunology. 16:1994;599-608
230. Roura X., Sánchez A., Ferrer L. Diagnosis of canine leishmaniasis by a polymerase chain reaction technique. Veterinary Record. 144:1999;262-264
231. Rubin S.I., Krawiec D.R., Gelberg H., Shanks R.D. Nephrotoxicity of amphotericin B in dogs: a comparison of two methods of administration. Canadian Journal of Veterinary Research. 53:1989;23-28
232. Sacks D.L., Lal S.L., Shrivastava S.N., Blackwell J., Neva F.A. An analysis of T cell responsiveness in Indian kala-azar. Journal of Immunology. 151:1987;3712-3718
233. Santana D.M., Borja-Cabrera G.P., Paraguai de Souza E., Sturm N.R., Palatnik-de Souza C.B., Campbell D.A. Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis. Molecular and Biochemical Parasitology. 120:2002;315-319
234. Santos-Gomes G.M., Rosa R., Leandro C., Cortes S., Romao P., Silveira H. Cytokine expression during the outcome of canine experimental infection by Leishmania infantum. Veterinary Immunology and Immunopathology. 88:2002;21-30
235. Scalone A., De Luna R., Oliva G., Baldi L., Satta G., Vesco G., Mignone W., Turilli C., Mondesire R.R., Simpson D., Donoghue A.R., Frank G.R., Gradoni L. Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay. Veterinary Parasitology. 104:2002;275-285
236. Schurr E., Buschman E., Malo D., Gros P., Skamene E. Immunogenetics of mycobacterial infections: mouse-human homologies. Journal of Infectious Diseases. 161:1990;634-639
237. Semiao-Santos S.J., Harith A.E., Ferreira E., Pires C.A., Sousa C., Gusmao R. Ëvora district as a new focus for canine leishmaniasis in Portugal. Parasitology Research. 81:1995;235-239
238. Service M.W. Vector control. Where are we now? Bulletin of the Society for Vector Ecology. 17:1992;94-108
239. Shao Q.F. Surveillance of kala-azar following preliminary eradication. Chinese Journal of Entomology. 3:1982;35-37
240. Sideris V., Karagouni E., Papadopoulou G., Garifallou A., Dotsika E. Canine visceral leishmaniasis in the great Athens area, Greece. Parasite. 3:1996;125-130
241. Sideris V., Papadopoulou G., Dotsika E., Karagouni E. Asymptomatic canine leishmaniasis in Greater Athens area, Greece. European Journal of Epidemiology. 15:1999;271-276
242. Silva E.S., Gontijo C.M.F., Pirmez C., Fernandes O., Brazil R.P. Detection of Leishmania DNA by polymerase chain reaction on blood samples from dogs with visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene. 65:2001;896-898
243. Slappendel R.J. Canine leishmaniasis. A review based on 95 cases in The Netherlands. Veterinary Quarterly. 10:1988;1-16
244. Slappendel R.J., Teske E. The effect of intravenous or subcutaneous administration of meglumine antimoniate (Glucantime®) in dogs with leishmaniasis. A randomized clinical trial. Veterinary Quarterly. 19:1997;10-13
245. Slappendel R.J., Teske E. A review of canine leishmaniasis presenting outside endemic areas. Killick-Kendrick R. Canine Leishmaniosis: an update. 1999;54-59 Hoechst Roussel Vet, Barcelona
246. Solano-Gallego L., Llull J., Ramos G., Riera C., Arboix M., Alberola J., Ferrer L. The Ibizian hound presents a predominantly cellular immune response against natural Leishmania infection. Veterinary Parasitology. 90:2000;37-45
247. Solano-Gallego L., Riera C., Roura X., Iniesta L., Gállego M., Valladares J.E., Fisa R., Castillejo S., Alberola J., Ferrer L., Arboix M., Portús M. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Veterinary Parasitology. 96:2001a;265-276
248. Solano-Gallego L., Llull J., Arboix M., Ferrer L., Alberola J. Evaluation of the efficacy of two leishmanins in asymptomatic dogs. Veterinary Parasitology. 102:2001b;163-166
249. Solano-Gallego L., Morell P., Arboix M., Alberola J., Ferrer L. Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology. Journal of Clinical Microbiology. 39:2001c;560-563
250. Soto M., Requena J.M., Quijada L., Guzmán F., Patarroyo M.E., Alonso C. Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis. Immunology Letters. 48:1995a;23-28
251. Soto M., Requena J.M., Quijada L., García M., Guzmán F., Patarroyo M.E., Alonso C. Mapping of the linear antigenic determinants from the Leishmania infantum histone H2A recognized by sera from dogs with leishmaniasis. Immunology Letters. 48:1995b;209-214
252. Soto M., Requena J.M., Quijada L., Angel S.O., Gómez L.C., Guzmán F., Patarroyo M.E., Alonso C. During active viscerocutaneous leishmaniasis the anti-P2 humoral response is specifically triggered by the parasite P proteins. Clinical and Experimental Immunology. 100:1995c;246-252
253. Soto M., Requena J.M., Quijada L., Gómez L.C., Guzman F., Patarroyo M.E., Alonso C. Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis. Clinical and Experimental Immunology. 106:1996;454-461
254. Soto M., Requena J.M., Quijada L., Alonso C. Multicomponent chimeric antigen for serodiagnosis of canine visceral leishmaniasis. Journal of Clinical Microbiology. 36:1998;58-63
255. Soto M., Requena J.M., Quijada L., Pérez M.J., Nieto C.G., Guzmán F., Patarroyo M.E., Alonso C. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis. Clinical and Experimental Immunology. 115:1999;342-349
256. Spreng D. Leishmanial polyarthritis in two dogs. Journal of Small Animal Practice. 34:1993;559-563
257. Sundar S., Gupta L.B., Makharia M.K., Singh M.K., Voss A., Rosenkaimer F., Engel J., Murray H.W. Oral treatment of visceral leishmaniasis with miltefosine. Annals of Tropical Medicine and Parasitology. 93:1999;589-597
258. Sundar S., Makharia A., More D.K., Agrawal G., Voss A., Fisher C., Bachman P., Murray H.W. Short-course of oral miltefosine treatment of visceral leishmaniasis. Clinical Infectious Diseases. 31:2000;1110-1113
259. Swenson C.L., Silverman J., Stromberg P.C., Johnson S.E., Wilkie D.A., Eaton K.A., Kociba G.J. Visceral leishmaniasis in an English foxhound from an Ohio research colony. Journal of the American Veterinary Medical Association. 193:1988;1089-1092
260. Tafuri W.L., Rosa de Oliveira M., Melo M.N., Tafuri W.L. Canine visceral leishmaniasis: a remarkable histopathological picture of one case reported from Brazil. Veterinary Parasitology. 96:2001;203-212
261. Tassi P., Madonna M., Carli S., Belloli C., De Natale G., Ceci L., Marcotrigiano G.O. Pharmacokinetics of N-methylglucamine antimoniate after intravenous, intramuscular and subcutaneous administration in dog. Research on Veterinary Sciences. 56:1994;114-150
262. Tayeh, A., Jalouk, L. and Al-Khiami, A.M. (1997). A cutaneous leishmaniasis control trial using pyrethroid-impregnated bednets in villages near Aleppo, Syria. Geneva: World Health Organization, mimeographed document WHO/LEISH/97.41
263. Tesh R.B. Control of zoonotic visceral leishmaniasis: is it time to change strategies? American Journal of Tropical Medicine and Hygiene. 52:1995;287-292
264. Tesh R.B., Papaevangelou G. Effect of insecticide spraying for malaria control on the incidence of sandfly fever in Athens, Greece. American Journal of Tropical Medicine and Hygiene. 26:1977;163-166
265. Travi B.L., Tabares C.J., Cadena H., Ferro C., Osorio Y. Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies. American Journal of Tropical Medicine and Hygiene. 64:2001;119-124
266. Travi B.L., Ferro C., Cadena H., Montoya-Lerma J., Adler G.H. Canine visceral leishmaniasis: dog infectivity to sand flies from non-endemic areas. Research in Veterinary Science. 72:2002a;83-86
267. Travi B.L., Osorio Y., Melby P.C., Chandrasekar B., Arteaga L., Saravia N.G. Gender is a major determinant of the clinical evolution and immune response in hamsters infected with Leishmania spp. Infection and Immunity. 70:2002b;2288-2296
268. Tryphonas L., Zawidzka Z., Bernard M.A., Janzen E.A. Visceral leishmaniasis in a dog: clinical, hematological and pathological observations. Canadian Journal of Comparative Medicine. 41:1977;1-12
269. Valladares J.E., Alberola J., Esteban M., Arboix M. Disposition of antimony after the administration of N-methylglucamine antimoniate to dogs. Veterinary Record. 138:1996;181-183
270. Valladares J.E., Riera C., Alberola J., Gállego M., Portús M., Cristòfol C., Franquelo C., Arboix M. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Veterinary Parasitology. 75:1998;33-40
271. Vamvakidis C.D., Koutinas A.F., Kanakoudis G., Georgiadis G., Saridomichelakis M. Masticatory and skeletal muscle myositis in canine leishmaniasis (Leishmania infantum). Veterinary Record. 146:2000;698-703
272. Vercammen F., De Deken R. Antibody kinetics during allopurinol treatment in canine leishmaniasis. Veterinary Record. 139:1996;264
273. Vercammen F., Berkvens D., Le Ray D., Jacquet D., Vervoort T. Development of a slide ELISA for canine leishmaniasis and comparison with four serological tests. Veterinary Record. 141:1997;328-330
274. Vexenat J.A., Olliaro P.L., Fonseca de Castro J.A., Furtado J.H., Tavares J.P., Miles M.A. Clinical recovery and limited cure in canine visceral leishmaniasis treated with aminosidine (paromomycin). American Journal of Tropical Medicine and Hygiene. 58:1998;448-453
275. Vianna V.L., Takiya C.M., de Brito-Gitirana L. Histopathologic analysis of hamster hepatocytes submitted to experimental infection with Leishmania donovani. Parasitology Research. 88:2002;829-836
276. Vieira J.B., Lacerda M.M., Marsden P.D. National reporting of leishmaniasis: the Brazilian experience. Parasitology Today. 10:1990;339-340
277. Viñuelas J., Garcia-Alonso M., Ferrando L., Navarrete I., Molano I., Miron C., Carcelen J., Alonso C., Nieto C.G. Meningeal leishmaniosis induced by Leishmania infantum in naturally infected dogs. Veterinary Parasitology. 101:2001;23-27
278. Vioukov V.N. Control of transmission. Peters W., Killick-Kendrick R. The Leishmaniases in Biology and Medicine. 2:1987;909-928 Academic Press, London
279. Vouldoukis I., Drapier J.C., Nussler A.K., Tselentis Y., Da Silva O.A., Gentilini M., Mossalayi D.M., Monjour L., Dugas B. Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway. Antimicrobial Agents and Chemotherapy. 40:1996;253-256
280. Ward R.D. Vector biology and control. Chang K.P., Bray R.S. Leishmaniasis. 1985;199-212 Elsevier, Amsterdam
281. WHO (1990). Control of the Leishmaniases. Geneva: World Health Organization, Technical Report Series, No. 793
282. Woody B.J., Hoskins J.D. Ehrlichial diseases of dogs. Veterinary Clinics of North America, Small Animal Practice. 21:1991;75-98
283. Xiong G., Jin C., Hong Y., Su Z., Xue P., Xie W., Zhang A., Li G., Gao B. [Studies on the deltamethrin-medicated bath of domestic dogs for interrupting visceral leishmaniasis transmission]. Chinese Journal of Parasitology and Parasitic Diseases. 13:1995;178-181.. [In Chinese, with English abstract.]
284. Zerpa O., Ulrich M., Negrón E., Rodríguez N., Centeno M., Rodríguez V., Barrios R.M., Belizario D., Reed S., Convit J. Canine visceral leishmaniasis on Margarita Island (Nueva Esparta, Venezuela). Transactions of the Royal Society of Tropical Medicine and Hygiene. 94:2000;484-487